GS-100 yɛ AAV9 a ɛsan bɔ ne ho a ɛbɔ onipa NGLY1 gene. US Food and Drug Administration ne European Medicine Agency (EMA) de no ato hɔ sɛ aduru a wɔntumi nyɛ ho hwee. FDA de no too hɔ sɛ yare a ɛtaa ba nkwadaa mu wɔ 2021 mu, na wɔsan de no too hɔ sɛ aduru a wɔtumi yɛ ho adwuma ntɛmntɛm wɔ afe a ɛtwaam no mu.
#SCIENCE #Twi #CU
Read more at Clinical Trials Arena